DM Clinical Research’s Post

🚀 Proud to Be Founding Members of the AMRC – A New Era for Multisite Clinical Research! 🌟 Today marks a transformative moment for the clinical research industry with the launch of the Association of Multisite Research Corporations (AMRC), and we’re honored to be a founding member of this groundbreaking organization. The AMRC unites 14 pioneering organizations, representing over 400 research sites, nearly 1,000 principal investigators, and more than 7,000 staff, with a shared mission: to revolutionize clinical trials through the multisite model. We are immensely proud that our CEO, William Furness, is a founding board member, helping to guide this ambitious vision to elevate standards, streamline operations, and create a more efficient, scalable, and patient-centric future for clinical research. Why does this matter? -Standardized systems and centralized operations will redefine how we deliver consistency and data integrity. -A patient-first approach ensures greater accessibility and participation across diverse populations. -Collaboration across the AMRC’s powerful network will drive innovation, efficiency, and better outcomes for sponsors, investigators, and, most importantly, patients. -With global demand for larger, faster, and more robust trials at an all-time high, the AMRC is answering the call, creating an alliance that is aligned with FDA priorities and poised to shape the future of our industry. We’re proud to stand alongside our peers in this monumental endeavor. Together, we will lead the charge to innovate, improve, and deliver hope to patients around the world! Learn more at: 🌎 amrc.org #AMRC #ClinicalResearch #MultisiteTrials #Innovation #PatientCentricity #ResearchLeadership

Elevating clinical research site support with comprehensive budgets and accelerated site payments has emerged as a key strategy as sponsors and contract research organizations carefully consider how they can improve relationships with sites. Bill Garton explores more for Applied Clinical Trials Magazine. » https://bit.ly/3C9QtT9

💡 Let’s talk about leveling up clinical research site support! What’s the secret sauce? Comprehensive budgets + faster site payments = stronger partnerships and smoother collaborations. 🎯 Bill Garton breaks it all down in Applied Clinical Trials Magazine, sharing how sponsors and CROs can build trust and make a real impact. If you're in the clinical research world, this is a must-read! 👇 https://bit.ly/3C9QtT9 #ClinicalResearch #SiteSupport #Innovation

Commence Your Future Clinical Trials At AIIMS Hospital With BBMCT Commence Your Future Clinical Trials At AIIMS Hospital With BBMCT In the rapidly evolving landscape of healthcare and clinical research, starting clinical trials can be a pivotal move for researchers, pharmaceutical companies, and medical institutions. The British Biomedicine Clinical Trials (BBMCT) program at AIIMS Hospital provides a unique opportunity to initiate and manage clinical trials effectively. This blog explores the advantages of commencing trials at AIIMS with BBMCT’s assistance and how it can help you launch successful clinical research initiatives. ## Initiate Trials At AIIMS Hospital AIIMS Hospital, renowned for its cutting-edge healthcare facilities and research capabilities, is an ideal location to initiate clinical trials. With state-of-the-art infrastructure, the hospital offers various resources, including access to diverse patient populations, advanced diagnostic tools, and well-equipped research laboratories. Collaborating with AIIMS enables researchers to navigate the complexities of clinical trials efficiently while adhering to regulatory standards. The hospital’s strong emphasis on innovation and patient safety enhances the overall trial experience, ensuring high-quality data collection and analysis. ## Start Research With BBMCT Assistance The BBMCT program is designed to support researchers at every step of the clinical trial process. From study design to patient recruitment and data management, BBMCT provides comprehensive assistance that ensures trials are conducted seamlessly. Their team of experts offers invaluable guidance on regulatory compliance, ethical considerations, and trial protocols, helping researchers avoid common pitfalls. With BBMCT’s support, initiating research at AIIMS becomes a streamlined process, allowing researchers to focus on generating meaningful results that can contribute to medical advancements. ## Commence Trials At AIIMS Shortly Time is often of the essence in clinical research. The BBMCT program facilitates the swift commencement of clinical trials at AIIMS Hospital, helping researchers get their studies off the ground without unnecessary delays. BBMCT has established protocols and procedures that enable rapid approval and onboarding, allowing trials to begin shortly after planning. This efficiency ensures that researchers can capitalize on timely opportunities, whether developing new treatments or testing innovative medical devices, ultimately speeding up the pace of medical discoveries. ## Collaborate With BBMCT For Trials Collaboration is crucial for the success of any clinical trial. By partnering with BBMCT, researchers can tap into a wealth of knowledge and resources. BBMCT’s network of professionals includes experts in various fields, including biostatistics, clinical pharmacology, and regulatory affairs.

Great comprehensive overview: Strategic Emergence of Site Networks in Clinical Research from Applied Clinical Trials. Integrated site networks are emerging rapidly in the clinical research industry. https://lnkd.in/gk_Tmb-4 #sitenetwork #clinicalresearch #clinicaltrials

🌟💬 Xtalks Spotlight: We spoke with Dr. Ieuan Clay, Director of Science at VivoSense, Inc., about integrating validated digital health technologies (#DHTs) into clinical research. With clinical trial costs ranging from $1 billion to $2 billion, timelines of 5-10 years, and success rates below 10%, the need for reform is clear. Dr. Clay highlights how DHTs can make trials faster, less costly, more patient-centric, and reflective of real-world outcomes. ⏩ Watch and read the full interview with Dr. Clay here: https://buff.ly/4bXY5oe #DigitalHealth #DigitalHealthTechnology #DigitalTechnologies #DigitalClinicalTrials #DigitalEndpoints

Celebrate #ClinicalTrialsDay today by checking out the newly released Toward a National Action Plan for Achieving Diversity in Clinical Trial, which includes eight domains and action steps intended to drive system-wide collective action. The need to improve diversity in clinical trials has been evident for many years, but a multi-sector action plan for system-wide, sustainable change was lacking. This foundational document is a call to collective action that has been (and continues to be) informed by the shared wisdom of hundreds of leaders in health equity and representation involved in a series of convenings over the last year. These include meetings held by the Clinical Trials Transformation Initiative (CTTI) in June 2023, the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) in September 2023, Milken Institute’s FasterCures in November 2023, and the meeting today May 20, 2024, hosted by the National Academies Forum on Drug Discovery, Development, and Translation. We call on each of us from across the clinical research enterprise to step forward and commit to working together to implement this National Action Plan and achieve representative clinical trials. https://lnkd.in/eYa3nNYW

I adore Clinical Trials Day! Let's pave the way for innovation in clinical research together. 🌟From improving feasibility to building trust, there's much we can do to accelerate progress. What steps do YOU think we should prioritize? #clinicalresearch #ClinicalTrialsDay #collaboration

Discover strategies to boost enrollment at clinical research sites in our latest blog. Get actionable tips to address common challenges and ensure successful clinical trials. » https://bit.ly/3ZMrle2 #clinicalresearch #nonenrollingsites #researchsites